Mirosław Majewski

1.7k total citations
28 papers, 1.4k citations indexed

About

Mirosław Majewski is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Mirosław Majewski has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 10 papers in Hematology and 9 papers in Immunology. Recurrent topics in Mirosław Majewski's work include Chronic Lymphocytic Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Eosinophilic Disorders and Syndromes (8 papers). Mirosław Majewski is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Eosinophilic Disorders and Syndromes (8 papers). Mirosław Majewski collaborates with scholars based in Poland, United States and Russia. Mirosław Majewski's co-authors include Mariusz A. Wasik, Malgorzata Nieborowska-Skorska, Tomasz Skórski, Artur Słupianek, Bruno Calabretta, Plamen Kossev, Magdalena Korecka, W. Schüler, Leslie M. Shaw and Paolo Salomoni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Mirosław Majewski

27 papers receiving 1.3k citations

Peers

Mirosław Majewski

ONCOL

PFM

HEMAT

IMMUN

Yvona Brychtová Czechia

Cristiana Carniti Italy

Gisele W. B. Colleoni Brazil

Giuliana Cavalloni Italy

Iman Jilani United States

Todd M. Zimmerman United States

Cristina Rabascio Italy

Ciara L. Freeman United States

Karoline Sonneck Austria

Norman M. Law United States

Yvona Brychtová Czechia

Mirosław Majewski

422 ×0.8

294 ×0.6

ONCOL

450 ×1.3

PFM

221 ×0.7

HEMAT

385 ×1.3

IMMUN

Citations per year, relative to Mirosław Majewski Mirosław Majewski (= 1×) peers Yvona Brychtová

Countries citing papers authored by Mirosław Majewski

Since Specialization

Citations

This map shows the geographic impact of Mirosław Majewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirosław Majewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirosław Majewski more than expected).

Fields of papers citing papers by Mirosław Majewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirosław Majewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirosław Majewski. The network helps show where Mirosław Majewski may publish in the future.

Co-authorship network of co-authors of Mirosław Majewski

This figure shows the co-authorship network connecting the top 25 collaborators of Mirosław Majewski. A scholar is included among the top collaborators of Mirosław Majewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirosław Majewski. Mirosław Majewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Butrym, Aleksandra, Mirosław Majewski, Justyna Rybka, Kazimierz Kuliczkowski, & Grzegorz Mazur. (2013). High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients. Medical Oncology. 30(2). 560–560. 8 indexed citations

Butrym, Aleksandra, Mirosław Majewski, Justyna Rybka, Kazimierz Kuliczkowski, & Grzegorz Mazur. (2012). High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients. Leukemia Research. 36(7). 876–880. 14 indexed citations

Lech‐Marańda, Ewa, Wojciech Młynarski, Olga Grzybowska‐Izydorczyk, et al.. (2012). Polymorphisms of TNF and IL‐10 genes and clinical outcome of patients with chronic lymphocytic leukemia. Genes Chromosomes and Cancer. 52(3). 287–296. 29 indexed citations

Helbig, Grzegorz, et al.. (2009). T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. Haematologica. 94(9). 1236–1241. 43 indexed citations

Lewandowski, Krzysztof, Krzysztof Warzocha, Andrzej Hellmann, et al.. (2009). Frequency of BCR‑ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib. A final report of the MAPTEST study. Polskie Archiwum Medycyny Wewnętrznej. 119(12). 789–794. 13 indexed citations

Wojtkiewicz, Joanna, et al.. (2008). Polymorphism of alpha-lactalbumin gene and expression of the p24 protein in the B and T lymphocyte subpopulations in cows naturally infected with bovine leukaemia virus. Bulletin of the Veterinary Institute in Pulawy. 52(3).

Prochorec‐Sobieszek, Monika, Grzegorz Rymkiewicz, Mirosław Majewski, et al.. (2008). Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy. Arthritis Research & Therapy. 10(3). R55–R55. 21 indexed citations

Helbig, Grzegorz, Beata Stella‐Hołowiecka, Mirosław Majewski, et al.. (2008). A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1‐PDGFRA‐expressing patients. British Journal of Haematology. 141(2). 200–204. 59 indexed citations

Pieńkowska‐Grela, Barbara, et al.. (2007). Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript. Cancer Genetics and Cytogenetics. 174(2). 111–115. 15 indexed citations

10.

Helbig, Grzegorz, et al.. (2007). Interferon induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation. Haematologica. 92(11). e118–e119. 17 indexed citations

11.

Majewski, Mirosław, Ilona Seferyńska, Agnieszka Tomaszewska, et al.. (2007). Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT.. PubMed. 12(3). 33–8. 8 indexed citations

12.

Kasprzycka, Monika, Mirosław Majewski, Andrzej Ptasznik, et al.. (2006). Expression and Oncogenic Role of Brk (PTK6/Sik) Protein Tyrosine Kinase in Lymphocytes. American Journal Of Pathology. 168(5). 1631–1641. 33 indexed citations

13.

Fiedorowicz, Anna, et al.. (2004). PROFILE OF PERIPHERAL BLOOD LYMPHOCYTES IN THE FIRST MONTHS OF LIFE OF HEIFERS ORIGINATING FROM A LEUKAEMIC HERD. Bulletin of the Veterinary Institute in Pulawy. 48(4). 2 indexed citations

14.

Majewski, Mirosław, Magdalena Korecka, Joanne Joergensen, et al.. (2003). Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Transplantation. 75(10). 1710–1717. 127 indexed citations

15.

Zhang, Qian, Liquan Xue, Mirosław Majewski, et al.. (2002). Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma. The Journal of Immunology. 168(1). 466–474. 220 indexed citations

16.

Paessler, Michele, Plamen Kossev, Donald E. Tsai, et al.. (2002). Expression of SHP-1 Phosphatase Indicates Post-Germinal Center Cell Derivation of B-Cell Posttransplant Lymphoproliferative Disorders. Laboratory Investigation. 82(11). 1599–1606. 13 indexed citations

17.

Majewski, Mirosław, Magdalena Korecka, Plamen Kossev, et al.. (2000). The immunosuppressive macrolide RAD inhibits growth of human Epstein–Barr virus-transformed B lymphocytes in vitro and in vivo : A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proceedings of the National Academy of Sciences. 97(8). 4285–4290. 181 indexed citations

18.

Skórski, Tomasz, Paweł Włodarski, Laurence Dahéron, et al.. (1998). BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac. Proceedings of the National Academy of Sciences. 95(20). 11858–11862. 84 indexed citations

19.

Skórski, T, Malgorzata Nieborowska-Skorska, Paweł Włodarski, et al.. (1997). Treatment of Philadelphia1 Leukemia in Severe Combined Immunodeficient Mice by Combination of Cyclophosphamide and bcr/abl Antisense Oligodeoxynucleotides. JNCI Journal of the National Cancer Institute. 89(2). 124–133. 50 indexed citations

20.

Seferyńska, Ilona, et al.. (1995). [A relationship between the breakpoint of the bcr gene and some hematologic parameters in patients with chronic myelogenous leukemia].. PubMed. 26(4). 385–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact